An observational study in Cesarean Scar Pregnancy, sponsored by Women's Hospital School Of Medicine Zhejiang University. Recruiting at 1 site in China. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-12.
Sponsored by Women's Hospital School Of Medicine Zhejiang University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 42 studies in Cicatrix with a site in China — 8 open to participants now, 8 under way, none of them phase 3. Cicatrix · China.
Among the 42 studies in Cicatrix with a site in China, this one is one of 6 that started in 2025, is one of 8 observational ones, and was the 30th registered.
616 studies on the registry are indexed under Cicatrix; 117 are open to participants now.
Browse Cicatrix studies →8 of the 42 studies in Cicatrix with a site in China are open now. Recruiting first, the newest first:
Peking University Third Hospital · Sites in China
Ages 20–50
Mabwell (Shanghai) Bioscience Co., Ltd. · Sites in China
Ages 18+
LIAO Peng · Sites in China
Ages 3–6
First Affiliated Hospital, Sun Yat-Sen University · Sites in China
Ages up to 80
Chinese Medical Association · Sites in China
Ages 18–70
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 69 Cicatrix studies recruiting now, 34 (49%) set no upper age limit and 31 (45%) stop at 75 or younger; 11 take children under 18; 16 take healthy volunteers.
This study: 18 Years and older · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
42 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 5 · Phase 2 7 · Phase 3 2
First in 2011; this study’s year is marked. 6 started in 2025.
This study's planned enrollment of 82 is close to the median of 80 across 69 observational studies indexed under Cicatrix.
Median enrollment 50 across the 34 interventional studies, 119 across the 8 observational. Of the 17 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
3 of 42 have an industry lead sponsor. The 10 most frequent:
Women's Hospital School Of Medicine Zhejiang University is the lead sponsor of 80 studies on the registry; 50 are open to participants now.
Women's Hospital School Of Medicine Zhejiang University has 2 studies filed under Cicatrix — fewer than ten, so there is no comparison to draw.
4 of the studies in Cicatrix with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07576608Mabwell (Shanghai) Bioscience Co., Ltd.A Phase II Study of 9MW3811 in Patients With Pathological Scar | 2026-12 |
| NCT07608094Women's Hospital School Of Medicine Zhejiang UniversityThe Treatment Outcomes of Cesarean Scar Pregnancy | 2026-12-31 |
| NCT07620769CLASSYS Inc.Safety and Efficacy Evaluation of the Radiofrequency Therapeutic Device for the Treatment of Atrophic Acne Scars | 2027-03 |
| NCT07849010Peking University Third HospitalDisposable Noninvasive Skin Closure for Promoting Postoperative Wound Healing and Preventing Surgical Skin Scarring | 2027-06-30 |
Add all 4 to your calendar (.ics) → With an account.
Among the 42 studies in Cicatrix with a site in China, from their registry updates:
This tab as a report to print or save as PDF → With an account.
A prospective randomized controlled study evaluating the impact of various treatment modalities for cesarean scar pregnancy on treatment outcomes and pregnancy outcomes
The excisional surgeries were conducted via excision of the cesarean scar pregnancy and closure of the uterine incision through a transvaginal approach or hysteroscopy-assisted laparoscopic approach.
Conservative surgeries refer to the removal of intrauterine pregnancy tissues through ultrasound-guided vacuum aspiration or hysteroscopic surgery.
A prospective randomized controlled study evaluating the impact of various treatment modalities for cesarean scar pregnancy on treatment outcomes and pregnancy outcomes. The excisional surgeries were conducted via excision of the cesarean scar pregnancy and closure of the uterine incision through a transvaginal approach or hysteroscopy-assisted laparoscopic approach.
Conservative surgeries refer to the removal of intrauterine pregnancy tissues through ultrasound-guided vacuum aspiration or hysteroscopic surgery.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
The excisional surgeries were conducted via excision of the cesarean scar pregnancy and closure of the uterine incision through a transvaginal approach or hysteroscopy-assisted laparoscopic approach.
Other: different surgical treatment
Conservative surgeries refer to the removal of intrauterine pregnancy tissues through ultrasound-guided vacuum aspiration or hysteroscopic surgery.
Other: different surgical treatment
The excisional surgeries were conducted via excision of the cesarean scar pregnancy and closure of the uterine incision through a transvaginal approach or hysteroscopy-assisted laparoscopic approach. Conservative surgeries refer to the removal of intrauterine pregnancy tissues through ultrasound-guided vacuum aspiration or hysteroscopic surgery.
successful surgical treatment
successful treatment rate after surgery
Time frame: One day after surgery
complication
severe complication rate after surgery
Time frame: One day after surgery
subsequent pregnancy rate
subsequent pregnancy rate after surgery
Time frame: Up to 24 months after surgery without contraception and the time since the last menstrual period is 4 weeks or more.
CSP recurrence rate
CSP recurrence rate after surgery
Time frame: Up to 24 months after surgery without contraception
pregnancy interval
pregnancy interval after surgery
Time frame: Up to 24 months (the time interval between the cessation of contraception after surgery and the time of last menstrual period of the subsequent pregnancy)
Plan to share: No
No publications or documents are linked to this record.
Started Aug 2025 (actual). Primary completion is estimated for Dec 2026, 16 months after the start.
Of 23 observational studies under Cicatrix, half reached primary completion within 40 months of starting (the median), counting those still running; a quarter within 7. This study's planned 16 months is below that.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Women's Hospital School Of Medicine Zhejiang University